Preclinical evidence suggests that fluoxetine can radiosensitize glioma cells, inhibit STAT3-mediated metastasis in osteosarcoma, and reverse chemotherapy resistance (155–157). This evidence concerns the gene STAT3 and central nervous system cancer.